Successful Second Business Development Conference Held in Munich
At the beginning of June, BIO Deutschland, in cooperation with EBE (European Biopharmaceutical Enterprises) organised an exclusive conference in Munich for the second time. Some 100 CEOs and executives from large and medium-sized (bio)-pharmaceutical companies from Europe and the USA had the opportunity to network intensively and actively.
The conference was supported by international companies such as Biogen Idec, Boehringer Ingelheim, Genzyme, Roche, Amgen and Nomura Code and was held at the Hotel Le Meridien on 5 and 6 June. The two main conference topics were (1) new successful business development strategies and (2) to what extent are good management and innovation decisive in the success of a company?
Managers from biotech and pharmaceutical companies from Europe and abroad discussed concrete case studies in Munich and spoke intensively about questions concerning business development and joint partnerships. During the conference there was also a debate about the extent to which the new generations of innovative drugs will make a new type of business cooperation necessary.
As a result of the extraordinarily good response, BIO Deutschland and EBE are planning to co-host the conference in Germany again in 2009.